Skip to main content
Clinical Trials/CTRI/2023/02/049737
CTRI/2023/02/049737Completed未知

To evaluate the Safety & Anti-dandruff efficacy of test products & test regimen in comparison to placebo & control on healthy human volunteers suffering from dandruff.

nilever Industries Pvt Ltd0 sites346 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
346

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Female and male participants in the ratio of 2:1 in general good health.
  • 2. Participants in the age group 18-45 years (both the ages inclusive).
  • 3. Participants willing to give a written informed consent and agree to come for a regular follow up visit.
  • 4. Participants with mild dandruff score of = 40 (adherent (ASFS) + non-adherent dandruff (non-ASFS))
  • 5. Participants willing to abide by and comply with the study protocol.
  • 6. Participants who have not participated in a similar investigation in the past three months.
  • 7. Participants who agree to refrain from using hair dye / hair colour /henna during the study period.
  • 8. Participants willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration
  • 9. Participants willing to refrain from any other anti-dandruff treatment/ products (including lotions/ home remedies/ oils/ serum/ mask) during the course of the study
  • 10. Participants who agree to use test product & regimen (including hair oils).

Exclusion Criteria

  • 1. Participants who have undergone hair growth treatment within 3 months before screening into the study.
  • 2. Participants having any active scalp disease which may interfere in the study – dermatologist’s judgement.
  • 3. Participants with medicated / antidandruff oil will be excluded
  • 4. Participants (male) having androgenic alopecia, male pattern baldness’ not be included in study.
  • 5. Participants who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
  • 6. Participants (females) who are pregnant or lactating
  • 7. Participants who have had hair transplant.
  • 8. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
  • 9. Chronic illness which may influence the cutaneous state.
  • 10. Participants participating in other similar cosmetic or therapeutic trial within last three months
  • 11. Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
  • 12. Participants (males) who are having androgenic alopecia, male pattern baldness

Investigators

Sponsor
nilever Industries Pvt Ltd

Similar Trials